(A) Most ALS respondents had mild or moderate disability (with lower ALSFRS-R inverted scores, on the left), while fewer had severe disability (higher ALSFRS-R inverted scores, on the right). (B) Most ALS respondents completed the questionnaire within four years of being diagnosed. A small number of long-term ALS survivors (on the right) also completed the questionnaire.</p
Objectives To evaluate response rate, data quality, score reliability and scaling assumptions of the...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
Objectives: Using the Wilson and Cleary model linking clinical variables to quality of life, we expl...
To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defin...
OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
OBJECTIVES: To evaluate response rate, data quality, score reliability and scaling assumptions of th...
The purpose of the study was to assess frequency and predictors of disability measures in ALS. One h...
International audienceObjectives were: i) to describe the phenotypic heterogeneity of incident amyot...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
<p>K-MMSE, Korean version of Mini Mental State Examination; CDR, Clinical Dementia Rating; Disease d...
Objectives To evaluate response rate, data quality, score reliability and scaling assumptions of the...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
Objectives: Using the Wilson and Cleary model linking clinical variables to quality of life, we expl...
To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defin...
OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
OBJECTIVES: To evaluate response rate, data quality, score reliability and scaling assumptions of th...
The purpose of the study was to assess frequency and predictors of disability measures in ALS. One h...
International audienceObjectives were: i) to describe the phenotypic heterogeneity of incident amyot...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
<p>K-MMSE, Korean version of Mini Mental State Examination; CDR, Clinical Dementia Rating; Disease d...
Objectives To evaluate response rate, data quality, score reliability and scaling assumptions of the...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that drama...